Ginsenoside Rg3 inhibits osteosarcoma progression by reducing circ_0003074 expression in a

Tehasi Wang1, Chengguang Zhang1, Shuren Wang2

  • 1Graduate School, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.

Abstract

Insights

Ginsenoside Rg3 inhibits osteosarcoma (OS) progression by targeting circ_0003074, miR-516b-5p, and KPNA4. This study reveals Rg3

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ginsenoside Rg3 (Rg3) shows anti-cancer properties in osteosarcoma (OS).
  • The role of circular RNA (circRNA) in Rg3's effects on OS remains unexplored.
  • This study investigates circ_0003074's function in Rg3-treated OS.

Purpose of the Study:

  • To elucidate the mechanism of Rg3's anti-cancer activity in OS.
  • To determine the role of circ_0003074 in Rg3-mediated OS progression.
  • To investigate the circ_0003074/miR-516b-5p/KPNA4 axis in OS.

Main Methods:

  • Quantitative real-time PCR and Western blotting for gene and protein expression analysis.
  • Cellular assays (viability, proliferation, apoptosis, migration, invasion) to assess Rg3 and circ_0003074 effects.
  • Dual-luciferase reporter and RNA immunoprecipitation assays to confirm molecular interactions.
  • Xenograft mouse models to evaluate Rg3's in vivo anti-tumor efficacy.

Main Results:

  • Circ_0003074 and KPNA4 were upregulated, while miR-516b-5p was downregulated in OS tissues.
  • Rg3 treatment decreased circ_0003074 expression, suppressed proliferation, migration, and invasion, and induced apoptosis in OS cells.
  • Circ_0003074 mediated these effects, with miR-516b-5p acting as a target of circ_0003074 and KPNA4 as a target of miR-516b-5p.
  • Rg3 inhibited tumor formation in vivo by regulating circ_0003074.

Conclusions:

  • Rg3 exerts anti-cancer effects in OS by modulating the circ_0003074/miR-516b-5p/KPNA4 pathway.
  • Circ_0003074 acts as an oncogene in OS, promoting proliferation, migration, and invasion.
  • Rg3 demonstrates potential as a therapeutic agent for osteosarcoma.